Additionally, CVID patients’ CD19+CD27+ B-cell compartment had lower ROS basal levels and even a significant decrease in ROS production after anti-BCR+IL-21 stimulation, compared to healthy controls. This evidence concerns the gene BCR and common variable immunodeficiency.